Lexology November 26, 2025
AI, Intellectual Property, and strategic partnerships shaping the sector
The life sciences sector stands at the crossroads of rapid technological advancement and evolving legal landscapes. Against this backdrop, we convened our Life Sciences seminar on 28 October, bringing together experts and stakeholders to discuss the latest developments. As artificial intelligence transforms drug discovery and research, and as global partnerships become increasingly complex, stakeholders must navigate new challenges in intellectual property, licensing, and collaboration. This article explores the critical issues facing researchers, legal professionals, and industry leaders, providing timely insights for anyone operating at the intersection of science, technology, and law. Here are 5 things you need to know.
#1 2025 US IPO surge: Opportunities, challenges, and sector trends
...







